Docaravimab - Research Grade Biosimilar, CAS [[2247196-23-0]], Unconjugated, Monoclonal
Artikelnummer:
PRS-21-903
| Artikelname: |
Docaravimab - Research Grade Biosimilar, CAS [[2247196-23-0]], Unconjugated, Monoclonal |
| Artikelnummer: |
PRS-21-903 |
| Hersteller Artikelnummer: |
21-903 |
| Alternativnummer: |
PRS-21-903-0.1 |
| Hersteller: |
ProSci |
| Kategorie: |
Antikörper |
| Immunogen: |
Mus musculus / Rabies Virus Strain ERA GP Ectodomain Epitope G-III |
| Konjugation: |
Unconjugated |
| Alternative Synonym: |
DOCARAVIMAB [INN],DOCARAVIMAB [WHO-DD],IMMUNOGLOBULIN G2, ANTI-(RABIES VIRUS STRAIN EVELYN-ROCKITNIKI-ABELSETH GLYCOPROTEIN ECTODOMAIN EPITOPE G-III) (MUS MUSCULUS MONOCLONAL .GAMMA.2-CHAIN), DISULFIDE WITH MUS MUSCULUS MONOCLONAL .KAPPA.-CHAIN, DIMER IM |
| Klonalität: |
Monoclonal |
| Konzentration: |
batch dependent |
| UniProt: |
P03524 |
| Puffer: |
PBS buffer pH 7.5 |
| Quelle: |
CHO cells |
| Reinheit: |
>95% |
| CAS Nummer: |
[2247196-23-0] |
| Application Verdünnung: |
For research use only . |
